Kenvue, the J&J Healthcare Spinoff, Has Disappointed Investors
The company went public in May. Let's see what the charts tell us.
No Place to Hide? I'm Asking Questions About Two Defensive Sectors
Why are the healthcare and utilities ETFs not going up now? Let's take a deep dive.
Centene Continues to Look and Trade Weak
I didn't like it then and I don't like it now.
AbbVie's Quant Upgrade Gets My Attention. Bullish Charts Keep It
With two approaches on the same page, here's how we'd trade this drugmaker's stock.
I've Got a Play for LifeMD as It Gets Its Life Together
LifeMD had one of the best quarters among my small cap holdings this earnings season -- let's see how to trade the telehealth name.
Zoetis' Shares May Struggle to Continue Their Rally
The advance is looking mature and a shift in strategy may be called for.
As Novo Nordisk Surges on Ozempic, Wegovy, Is the Stock Looking a Little Heavy?
Unbelievably, there may be more interest in weight loss than AI right now.
Viatris Has Been Bearish for One Reason — But Is Still an Intriguing Value Play
One earnings story that caught my eye was this pharmaceutical name.
This Is Not a Drill: Get Ready for Another Big Down Leg in the Stock Market
Traders and investors should take appropriation action.
Eli Lilly Soars as Mounjaro, Growth Products Take Off: We're Upping Our Target
Here's how traders can play the stock.